Key points are not available for this paper at this time.
In this study, an oral placebo response model of OA was developed that may quantitatively describe the placebo response at different baseline levels of symptoms. The findings may provide valuable references for future clinical trial design and decision-making.
Wen et al. (Mon,) studied this question.